Skip to content

Efficacy of Nalbuphine for Treatment of Post Anesthesia Shivering

Efficacy of Nalbuphine for Treatment of Post Anesthesia Shivering

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900023431
Enrollment
Unknown
Registered
2019-05-27
Start date
2017-06-01
Completion date
Unknown
Last updated
2019-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post Anesthesia Shivering

Interventions

Sponsors

Shenzhen Maternity and Child Healthcare Hospital, Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 35 Years

Inclusion criteria

Inclusion criteria: 120 pregnant women, who were scheduled for elective low segment caesarean section under combined spinal-epidural anesthesia, aged 20-35 years, with ASA class II were involved in this study.

Exclusion criteria

Exclusion criteria: The following pregnant women were excluded if they had contraindication of preoperative caesarean section, pregnancy complication, contraindication of spinal anesthesia, scar uterus, fetal distress, heart disease, history of psychoactive medication, recent fever, uncertain of anesthesia effects, high metal stress and intraoperative blood infusion.

Design outcomes

Primary

MeasureTime frame
significant reduction in shivering;

Secondary

MeasureTime frame
side effects;

Countries

China

Contacts

Public ContactSun Jing

Department of Anesthesiology, Shenzhen Maternity and Child Healthcare Hospital, Southern Medical University

187244758@qq.com+86 13501597110

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026